Eric Faulkner, RTI Health Solutions Director of US Market Access and Reimbursement, has been requested to provide expert input to President George W. Bush’s President’s Council of Advisors on Science and Technology (PCAST) at a private workshop to be held at Harvard University on November 28, 2007. This forum will bring together over 40 prominent US thought leaders on personalized medicine to discuss the role of pharmaceuticals, diagnostics, reimbursement, economics and health information technology (HIT) in implementing personalized medicine approaches in the US.
The PCAST (http://www.ostp.gov/PCAST/pcast.html) was originally established in 1990 to enable the President to receive advice from the private sector and academic community on technology, scientific research priorities, and math and science education.
The range of areas related to personalized medicine that PCAST intends to study, include:
- Regulation of therapies and related diagnostic tests by the FDA;
- Reimbursement of therapies and diagnostic tests by CMS and private insurance companies;
- Genomic diagnostics, intellectual property and related emerging patent issues (PTO);
- Patient privacy;
- Information technology and issues of electronic patient records and associated data/databases;
- Economics of personalized medicine;
- Personalized medicine technology/tools; and
- PM and related patient, physician and public education.
In addition to his responsibilities at RTI Health Solutions, Mr. Faulkner also serves as Director of the Genomic Biotech Institute (GBI) of the National Association of Managed Care Physicians (NAMCP) and Editor-in-Chief of the GBI special section of the Journal of Managed Care Medicine, Genomics and Biotechnology.